Remedent, Inc. (REMI)

[FrankLind]

China is booming (predictably)
http://www.marketwatch.com/story/remedent-announces-glamsmile-chinas-record-growth-2013-05-06

As a reminder, EBITDA margins are around 50%, minus 20% tax, at REMI has a 29 share of the net income remaining. (29% share of the business)

The risk with this stock is renegotiating the Excelsior debt to avoid possible dilution (which would be disastrous at these levels) and making a small profit on the non-China business to pay down remaining debt.

I am confident the debt can be renegotiated because Excelsior is described as a strategic lender by the CEO.

I would suggest anyone looking at it to wait for the CC/10q for mroe details.

If the above is successful, the company is very very undervalued at these prices.